Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.640
+0.030 (0.65%)
At close: Nov 14, 2025, 4:00 PM EST
4.600
-0.040 (-0.86%)
After-hours: Nov 14, 2025, 6:31 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $254.73 million as of November 14, 2025. Its market cap has increased by 46.75% in one year.
Market Cap
254.73M
Enterprise Value
174.97M
1-Year Change
46.75%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $254.73M, an increase of 14.54%. That is a compound annual growth rate of 3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 254.73M | -30.91% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |